Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

JULIE A PARSONS

Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology with Special Qualifications in Child Neurology

NPI
1396820031
CMS profile
602199
Location
AURORA, CO

General Payments · PY2018–2024

$164,246.96

  • Reported across 210 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$39,134.28

26 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Ultragenyx Pharmaceutical Inc. $18,373.25 7
NOVARTIS PHARMACEUTICALS CORPORATION $10,777.86 6
Genentech USA, Inc. $8,325.34 8
PFIZER INC. $1,298.00 1
Sarepta Therapeutics, Inc. $210.94 2
Biogen, Inc. $135.40 1
CATALYST PHARMACEUTICALS, INC. $13.49 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $3,740.43 11
PY2019 $19,967.30 56
PY2020 $24,482.01 52
PY2021 $11,863.42 17
PY2022 $36,884.76 26
PY2023 $28,174.76 22
PY2024 $39,134.28 26

Payment records · PY2024 (26)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Biogen, Inc. $135.40 03/03/2024 Food and Beverage Undisputed 01/23/2026 1104867076 CMS
CATALYST PHARMACEUTICALS, INC. $13.49 11/22/2024 Education Undisputed 01/23/2026 1144450754 CMS
Genentech USA, Inc. $93.99 08/09/2024 Food and Beverage Undisputed 01/23/2026 1133042672 CMS
Genentech USA, Inc. $83.54 08/10/2024 Travel and Lodging Undisputed 01/23/2026 1133042676 CMS
Genentech USA, Inc. $219.38 08/10/2024 Food and Beverage Undisputed 01/23/2026 1133042681 CMS
Genentech USA, Inc. $6,725.00 08/10/2024 Consulting Fee Undisputed 01/23/2026 1133042685 CMS
Genentech USA, Inc. $381.03 08/10/2024 Travel and Lodging Undisputed 01/23/2026 1133042689 CMS
Genentech USA, Inc. $128.25 08/10/2024 Food and Beverage Undisputed 01/23/2026 1133042693 CMS
Genentech USA, Inc. $525.39 08/10/2024 Travel and Lodging Undisputed 01/23/2026 1133042697 CMS
Genentech USA, Inc. $168.76 08/10/2024 Food and Beverage Undisputed 01/23/2026 1133042701 CMS
Novartis Pharmaceuticals Corporation $2,825.00 09/25/2024 Consulting Fee Undisputed 01/23/2026 1087339391 CMS
Novartis Pharmaceuticals Corporation $288.98 10/18/2024 Travel and Lodging Undisputed 01/23/2026 1087331903 CMS
Novartis Pharmaceuticals Corporation $124.98 10/18/2024 Food and Beverage Undisputed 01/23/2026 1087339389 CMS
Novartis Pharmaceuticals Corporation $149.93 10/19/2024 Food and Beverage Undisputed 01/23/2026 1087339393 CMS
Novartis Pharmaceuticals Corporation $303.97 10/19/2024 Travel and Lodging Undisputed 01/23/2026 1087339395 CMS
Novartis Pharmaceuticals Corporation $7,085.00 10/19/2024 Consulting Fee Undisputed 01/23/2026 1087339397 CMS
PFIZER INC. $1,298.00 08/01/2024 Honoraria Undisputed 01/23/2026 1131825902 CMS
Sarepta Therapeutics, Inc. $127.15 03/03/2024 Food and Beverage Undisputed 01/23/2026 1126540855 CMS
Sarepta Therapeutics, Inc. $83.79 03/03/2024 Travel and Lodging Undisputed 01/23/2026 1126540857 CMS
Ultragenyx Pharmaceutical Inc. $470.46 01/11/2024 Travel and Lodging Undisputed 01/23/2026 1153281315 CMS
Ultragenyx Pharmaceutical Inc. $436.69 02/13/2024 Travel and Lodging Undisputed 01/23/2026 1153281502 CMS
Ultragenyx Pharmaceutical Inc. $1,929.00 11/04/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1153284514 CMS
Ultragenyx Pharmaceutical Inc. $35.00 12/05/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1153281262 CMS
Ultragenyx Pharmaceutical Inc. $275.45 12/05/2024 Travel and Lodging Undisputed 01/23/2026 1153284694 CMS
Ultragenyx Pharmaceutical Inc. $437.65 12/05/2024 Travel and Lodging Undisputed 01/23/2026 1153284698 CMS
Ultragenyx Pharmaceutical Inc. $14,789.00 12/05/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1153284718 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.